People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Orthocon Inc | — | Biotechnology | Series A | $10.5M | $379.6M | 2009 |
Klaus Breiner, Ph.D at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Klaus Breiner, Ph.D on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alan Levy, Ph.D. | 1 | 3 |
| John Pacifico | 1 | 2 |
| Paul Sohmer, M.D. | 1 | 1 |
| Seth Rudnick, M.D. | 1 | 1 |
| David Knaack | 1 | 1 |
| Richard Kronenthal, Ph.D | 1 | 1 |
| Joyce Tsang, Ph.D | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.